Plain-English translation of NCT03117946 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying how your immune system responds when you receive radiation and chemotherapy at the same time to treat lung or head and neck cancer. Researchers believe that this combination treatment might trigger your body's immune cells to attack cancer more effectively, and they want to understand exactly how that happens. By analyzing blood samples from patients like you, they hope to learn how to make this treatment work even better.
Doctors know that combining radiation and chemotherapy can be powerful against certain cancers, but they don't fully understand how your immune system contributes to fighting the disease. This research could help doctors predict which patients will benefit most from this treatment and potentially improve how it works for everyone.
You will have your blood drawn at several timepoints: before your treatment starts, about 2–3 weeks after treatment begins, then again at 1 month, 3 months, and 12 months after your treatment ends. If your cancer progresses, an additional blood sample may be collected. Tumor tissue may also be collected if available. The study simply monitors your immune response — you continue receiving your regular cancer treatment as planned by your doctor.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
France